Current Neuro-Oncology

Volume 28 Number 9
31 March 2026

Home > Publications > Current Neuro-Oncology > Volume 28, Year 2026 > Number 9, 31 March

Lockhart Z, Ruiz VY, King Z, Kirnaz S, Jabbar Dar A, Abbas I, Oriko D, Cohen J, Loeb DM, Fox JL, Martin AM, Kobets AJ.
Treatment strategies for relapsed medulloblastoma in the pediatric population: illustrative case.
J Neurosurg Case Lessons. 2026 Mar 23;11(12):CASE25612. doi: 10.3171/CASE25612. PMID: 41871404. ˍ

Brentlinger MN, Patel J, Khan A, Castro-Echeverry E, Abdullaev Z, Aldape K, Lehman NL.
Diffuse pediatric-type high grade glioma, RTK1 subtype, subclass C with SYN2::PPARG fusion in an older adult.
CNS Oncol. 2026 Mar 25;15(1):2641996. doi: 10.1080/20450907.2026.2641996. PMID: 41877551. ˍ

Wright E, Billups C, Rush S, Li Y, Janns A, Michalski JM, Salloum R, de Blank P.
Cumulative dose of chemotherapy and survival outcomes in children with average risk medulloblastoma treated on Children's Oncology Group study ACNS0331.
Neuro Oncol. 2026 Mar 26:noag064. doi: 10.1093/neuonc/noag064. PMID: 41885589. ˍ

Botti A, Sghedoni R, Orlandi M, Paolani G, Ciammella P, Giaccherini L, Iotti C, Iori M.
A Pipeline for MRI-Guided dose painting by number radiation Therapy: GLIORAD - a phase I-II clinical trial in recurrent glioblastoma.
Phys Med. 2026 Mar 27;145:105773. doi: 10.1016/j.ejmp.2026.105773. PMID: 41903279. Trial registration ID: NCT04610229˰ ˍ

Liu H, Su Y, Zhang J, Chen X, Deng K, Chen L, Feng J, Wu X, Daniels C, Li Y, Zhang J, Zhao Y, Shi Y, Liu F, Feng Z, Wang D, Han D, Wang W, Wang M, Zhang J, Qi X, Li J, Gong J, Liu W, Tian Y, Chen R, Jiang T, Taylor MD, Li C, Tian Y, Qiu X.
Long-term outcomes by clinical and molecular risk stratification in patients with medulloblastoma receiving risk-adapted therapy.
Med. 2026 Mar 27;7(5):101076. doi: 10.1016/j.medj.2026.101076. PMID: 41903543˰ ˍ